Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab, Atc L04Ac07 For The Period December 1St, 2023 - November 30Th, 2024 (Plus Extension Option 1X12 Months)